vs
WM TECHNOLOGY, INC.(MAPS)与RECURSION PHARMACEUTICALS, INC.(RXRX)财务数据对比。点击上方公司名可切换其他公司
WM TECHNOLOGY, INC.的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.2倍($43.1M vs $35.5M),WM TECHNOLOGY, INC.净利率更高(-8.3% vs -304.2%,领先295.9%),RECURSION PHARMACEUTICALS, INC.同比增速更快(681.7% vs -9.7%),WM TECHNOLOGY, INC.自由现金流更多($-280.0K vs $-47.3M),过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高(60.5% vs -1.5%)
WM娱乐是韩国一家娱乐经纪公司,由前歌手李元敏创立于2008年,核心业务为艺人经纪管理,知名女团Oh My Girl便由该公司运营管理,2021年4月7日,WM娱乐被RBW公司收购。
Recursion Pharmaceuticals是一家临床阶段生物技术企业,依托人工智能技术和高通量生物实验体系,开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法,核心市场覆盖北美,与全球多家生物制药企业合作推进在研管线落地。
MAPS vs RXRX — 直观对比
营收规模更大
MAPS
是对方的1.2倍
$35.5M
营收增速更快
RXRX
高出691.4%
-9.7%
净利率更高
MAPS
高出295.9%
-304.2%
自由现金流更多
MAPS
多$47.0M
$-47.3M
两年增速更快
RXRX
近两年复合增速
-1.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $43.1M | $35.5M |
| 净利润 | $-3.6M | $-108.1M |
| 毛利率 | 94.9% | 59.8% |
| 营业利润率 | -13.5% | -304.8% |
| 净利率 | -8.3% | -304.2% |
| 营收同比 | -9.7% | 681.7% |
| 净利润同比 | -251.9% | 39.6% |
| 每股收益(稀释后) | — | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
MAPS
RXRX
| Q4 25 | $43.1M | $35.5M | ||
| Q3 25 | $42.2M | $5.2M | ||
| Q2 25 | $44.8M | $19.2M | ||
| Q1 25 | $44.6M | $14.7M | ||
| Q4 24 | $47.7M | $4.5M | ||
| Q3 24 | $46.6M | $26.1M | ||
| Q2 24 | $45.9M | $14.4M | ||
| Q1 24 | $44.4M | $13.8M |
净利润
MAPS
RXRX
| Q4 25 | $-3.6M | $-108.1M | ||
| Q3 25 | $2.5M | $-162.3M | ||
| Q2 25 | $1.4M | $-171.9M | ||
| Q1 25 | $1.6M | $-202.5M | ||
| Q4 24 | $2.4M | $-178.9M | ||
| Q3 24 | $3.3M | $-95.8M | ||
| Q2 24 | $716.0K | $-97.5M | ||
| Q1 24 | $1.2M | $-91.4M |
毛利率
MAPS
RXRX
| Q4 25 | 94.9% | 59.8% | ||
| Q3 25 | 95.0% | -183.8% | ||
| Q2 25 | 94.9% | -4.9% | ||
| Q1 25 | 95.0% | -48.0% | ||
| Q4 24 | 95.2% | -181.4% | ||
| Q3 24 | 95.3% | 53.7% | ||
| Q2 24 | 95.1% | 36.2% | ||
| Q1 24 | 94.8% | 19.1% |
营业利润率
MAPS
RXRX
| Q4 25 | -13.5% | -304.8% | ||
| Q3 25 | 4.6% | -3327.6% | ||
| Q2 25 | 4.4% | -916.8% | ||
| Q1 25 | 5.9% | -1297.9% | ||
| Q4 24 | 9.6% | -4042.4% | ||
| Q3 24 | 11.2% | -377.1% | ||
| Q2 24 | 2.7% | -697.4% | ||
| Q1 24 | 8.5% | -698.4% |
净利率
MAPS
RXRX
| Q4 25 | -8.3% | -304.2% | ||
| Q3 25 | 5.8% | -3135.3% | ||
| Q2 25 | 3.2% | -894.2% | ||
| Q1 25 | 3.7% | -1373.3% | ||
| Q4 24 | 4.9% | -3935.5% | ||
| Q3 24 | 7.2% | -367.5% | ||
| Q2 24 | 1.6% | -676.6% | ||
| Q1 24 | 2.8% | -662.4% |
每股收益(稀释后)
MAPS
RXRX
| Q4 25 | — | $-0.17 | ||
| Q3 25 | — | $-0.36 | ||
| Q2 25 | — | $-0.41 | ||
| Q1 25 | $0.02 | $-0.50 | ||
| Q4 24 | — | $-0.56 | ||
| Q3 24 | — | $-0.34 | ||
| Q2 24 | — | $-0.40 | ||
| Q1 24 | $0.01 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $62.4M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $57.2M | $1.1B |
| 总资产 | $190.7M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势,按日历期对齐
现金及短期投资
MAPS
RXRX
| Q4 25 | $62.4M | $743.3M | ||
| Q3 25 | — | $659.8M | ||
| Q2 25 | — | $525.1M | ||
| Q1 25 | — | $500.5M | ||
| Q4 24 | $52.0M | $594.4M | ||
| Q3 24 | — | $427.6M | ||
| Q2 24 | — | $474.3M | ||
| Q1 24 | — | $296.3M |
总债务
MAPS
RXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益
MAPS
RXRX
| Q4 25 | $57.2M | $1.1B | ||
| Q3 25 | $56.9M | $1.0B | ||
| Q2 25 | $52.7M | $919.1M | ||
| Q1 25 | $48.5M | $933.9M | ||
| Q4 24 | $36.1M | $1.0B | ||
| Q3 24 | $29.5M | $524.6M | ||
| Q2 24 | $24.5M | $584.4M | ||
| Q1 24 | $20.8M | $401.2M |
总资产
MAPS
RXRX
| Q4 25 | $190.7M | $1.5B | ||
| Q3 25 | $192.9M | $1.4B | ||
| Q2 25 | $188.1M | $1.3B | ||
| Q1 25 | $183.8M | $1.3B | ||
| Q4 24 | $181.9M | $1.4B | ||
| Q3 24 | $173.6M | $726.5M | ||
| Q2 24 | $168.0M | $775.9M | ||
| Q1 24 | $165.8M | $557.8M |
负债/权益比
MAPS
RXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $3.0M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-280.0K | $-47.3M |
| 自由现金流率自由现金流/营收 | -0.7% | -133.1% |
| 资本支出强度资本支出/营收 | 7.7% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $13.5M | $-378.3M |
8季度趋势,按日历期对齐
经营现金流
MAPS
RXRX
| Q4 25 | $3.0M | $-46.1M | ||
| Q3 25 | $6.4M | $-117.4M | ||
| Q2 25 | $11.1M | $-76.4M | ||
| Q1 25 | $5.7M | $-132.0M | ||
| Q4 24 | $9.4M | $-115.4M | ||
| Q3 24 | $7.2M | $-59.2M | ||
| Q2 24 | $12.7M | $-82.2M | ||
| Q1 24 | $7.4M | $-102.3M |
自由现金流
MAPS
RXRX
| Q4 25 | $-280.0K | $-47.3M | ||
| Q3 25 | $3.6M | $-117.6M | ||
| Q2 25 | $8.2M | $-79.6M | ||
| Q1 25 | $2.0M | $-133.8M | ||
| Q4 24 | $7.3M | $-116.7M | ||
| Q3 24 | $4.9M | $-63.8M | ||
| Q2 24 | $10.1M | $-83.4M | ||
| Q1 24 | $2.9M | $-109.0M |
自由现金流率
MAPS
RXRX
| Q4 25 | -0.7% | -133.1% | ||
| Q3 25 | 8.4% | -2272.5% | ||
| Q2 25 | 18.3% | -413.9% | ||
| Q1 25 | 4.5% | -907.4% | ||
| Q4 24 | 15.2% | -2567.7% | ||
| Q3 24 | 10.4% | -244.6% | ||
| Q2 24 | 21.9% | -578.5% | ||
| Q1 24 | 6.4% | -789.9% |
资本支出强度
MAPS
RXRX
| Q4 25 | 7.7% | 3.5% | ||
| Q3 25 | 6.8% | 4.7% | ||
| Q2 25 | 6.3% | 16.4% | ||
| Q1 25 | 8.2% | 12.4% | ||
| Q4 24 | 4.5% | 28.6% | ||
| Q3 24 | 5.1% | 17.5% | ||
| Q2 24 | 5.7% | 8.2% | ||
| Q1 24 | 10.2% | 48.2% |
现金转化率
MAPS
RXRX
| Q4 25 | — | — | ||
| Q3 25 | 2.61× | — | ||
| Q2 25 | 7.75× | — | ||
| Q1 25 | 3.44× | — | ||
| Q4 24 | 4.00× | — | ||
| Q3 24 | 2.17× | — | ||
| Q2 24 | 17.67× | — | ||
| Q1 24 | 5.97× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MAPS
| Services | $39.5M | 92% |
| Other | $3.6M | 8% |
RXRX
暂无分部数据